ABBV - AbbVie Inc AbbVie is a leading research-driven global biopharmaceutical company. The company produces drugs for several different therapeutic areas such as rheumatology, oncology, virology, neurology, etc.

AbbVie’s blockbuster drug, Humira is one of the best-selling drugs globally and accounts for nearly 60% of the company’s revenue. The drug is used to treat psoriasis and rheumatoid arthritis. Other key products include Lupron, Creon, Androgel, and Marinol. The company also has a robust late-stage pipeline across several therapeutic areas.

The company has a large distribution network consisting of AbbVie-owned distribution centers and warehouses from where AbbVie's products reach wholesalers, distributors, and government agencies worldwide. AbbVie operates through only one business segment - Pharmaceuticals.

DISCLOSURE: Please note that links to merchants mentioned within this post might be using an affiliate link. Using an affiliate link means that, at zero cost to you, I might earn a commission if you buy something through that affiliate link.

Key Investment Data

  • Ticker: nyse:ABBV
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Market Cap: 196.47B
  • P/E: 9.43
  • Dividend Yield: 4.68%
  • Payout Ratio (TTM): 137.20%


The competitive landscape is important as they compete for the same business. Below is the list of competitors in the same industry. While not displayed, a number of metrics you can also use to evaluate your picks are the Chowder Score, the Relative Strength Index (RSI), the Graham Number, and the Piotroski F-Score.

Ticker Ticker Company Market Cap P/E Aristocrat Graph SectorID IndustryID
JNJ NYSE:JNJ Johnson & Johnson 423.65 17.63 YES 1 8 35
PFE NYSE:PFE Pfizer Inc. 238.00 13.52 NO 1 8 35
LLY NYSE:LLY Lilly 223.78 29.13 NO 1 8 35
MRK NYSE:MRK Merck & Co., Inc. 204.10 13.97 NO 1 8 35
ABBV NYSE:ABBV AbbVie Inc 196.47 9.43 YES 1 8 35
BMY NYSE:BMY Bristol Myers Squibb Co. 127.24 8.47 NO 1 8 35
AMGN NASDAQ:AMGN Amgen Inc. 118.65 12.85 NO 1 8 35
GILD NASDAQ:GILD Gilead Sciences Inc. 85.32 8.25 NO 1 8 35

Top Picks By Bay St Experts

Expert stock analysts have shared their opinions, and sometimes prediction, on the company.

For more top picks from stock analysts on Bay Street, check the full list of top picks by expect stock analysts from investment and asset management firms.

Not all analysts are equal and they don't cover the same type of stocks. The analysts performance and ownership is tracked for comparison.

AbbVie Inc - FAQ

What is the stock ticker for AbbVie Inc?

The stock ticker for AbbVie Inc is NYSE:ABBV.

Is AbbVie Inc a good stock to buy?

You need to consider your investment strategy and how NYSE:ABBV can fit in your portfolio.

The current dividend income score of 5/10 and dividend growth score of 5/10. Those 2 metrics together should help you decide the fit for your portfolio. Be it for income or for growth.

Is AbbVie Inc a Buy, Sell or Hold?

The Dividend Snapshot Opportunity Score of 50 out of 100.

The score reflects the strength of a buy signal but it does not show a sell signal if it's low. The higher the better.

A sell signal is more difficult as it often relies on the reason you bought the stock in the first place.

DISCLOSURE: Please note that I may have a position in one or many of the holdings listed. For a complete list of my holdings, please see my Dividend Portfolio.

DISCLAIMER: Please note that this blog post represents my opinion and not an advice/recommendation. I am not a financial adviser, I am not qualified to give financial advice. Before you buy any stocks/funds consult with a qualified financial planner. Make your investment decisions at your own risk – see my full disclaimer for more details.